165 related articles for article (PubMed ID: 32247363)
1. The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications.
Kuter KZ; Cenci MA; Carta AR
Prog Brain Res; 2020; 252():131-168. PubMed ID: 32247363
[TBL] [Abstract][Full Text] [Related]
2. l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?
Del-Bel E; Bortolanza M; Dos-Santos-Pereira M; Bariotto K; Raisman-Vozari R
Synapse; 2016 Dec; 70(12):479-500. PubMed ID: 27618286
[TBL] [Abstract][Full Text] [Related]
3. l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Carta AR; Mulas G; Bortolanza M; Duarte T; Pillai E; Fisone G; Vozari RR; Del-Bel E
Eur J Neurosci; 2017 Jan; 45(1):73-91. PubMed ID: 27859864
[TBL] [Abstract][Full Text] [Related]
4. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
Lee Y; Lee S; Chang SC; Lee J
Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
[TBL] [Abstract][Full Text] [Related]
5. Glial reactions in Parkinson's disease.
McGeer PL; McGeer EG
Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
[TBL] [Abstract][Full Text] [Related]
6. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson's disease brain.
Rostami J; Fotaki G; Sirois J; Mzezewa R; Bergström J; Essand M; Healy L; Erlandsson A
J Neuroinflammation; 2020 Apr; 17(1):119. PubMed ID: 32299492
[TBL] [Abstract][Full Text] [Related]
7. The Mechanism and Function of Glia in Parkinson's Disease.
Zhang X; Zhang R; Nisa Awan MU; Bai J
Front Cell Neurosci; 2022; 16():903469. PubMed ID: 35722618
[TBL] [Abstract][Full Text] [Related]
8. Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
Bortolanza M; Cavalcanti-Kiwiatkoski R; Padovan-Neto FE; da-Silva CA; Mitkovski M; Raisman-Vozari R; Del-Bel E
Neurobiol Dis; 2015 Jan; 73():377-87. PubMed ID: 25447229
[TBL] [Abstract][Full Text] [Related]
9. Glia as a turning point in the therapeutic strategy of Parkinson's disease.
L' Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):349-72. PubMed ID: 20438439
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
11. Glial phagocytic clearance in Parkinson's disease.
Tremblay ME; Cookson MR; Civiero L
Mol Neurodegener; 2019 Apr; 14(1):16. PubMed ID: 30953527
[TBL] [Abstract][Full Text] [Related]
12. Glial mechanisms underlying substance use disorders.
Linker KE; Cross SJ; Leslie FM
Eur J Neurosci; 2019 Aug; 50(3):2574-2589. PubMed ID: 30240518
[TBL] [Abstract][Full Text] [Related]
13. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
14. mGlu receptors in the treatment of Parkinson's disease and L-DOPA-induced dyskinesia.
Sebastianutto I; Cenci MA
Curr Opin Pharmacol; 2018 Feb; 38():81-89. PubMed ID: 29625424
[TBL] [Abstract][Full Text] [Related]
15. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.
Mirza B; Hadberg H; Thomsen P; Moos T
Neuroscience; 2000; 95(2):425-32. PubMed ID: 10658622
[TBL] [Abstract][Full Text] [Related]
16. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3
Suarez LM; Alberquilla S; García-Montes JR; Moratalla R
J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.
Pisanu A; Boi L; Mulas G; Spiga S; Fenu S; Carta AR
J Neural Transm (Vienna); 2018 Aug; 125(8):1287-1297. PubMed ID: 29541852
[TBL] [Abstract][Full Text] [Related]
18. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
Kuter K; Olech Ł; Głowacka U
Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
[TBL] [Abstract][Full Text] [Related]
19. Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies.
Sharma S; Singh S; Sharma V; Singh VP; Deshmukh R
Biomed Pharmacother; 2015 Mar; 70():283-93. PubMed ID: 25776513
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory response in Parkinson's disease (Review).
Yan J; Fu Q; Cheng L; Zhai M; Wu W; Huang L; Du G
Mol Med Rep; 2014 Nov; 10(5):2223-33. PubMed ID: 25215472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
